DHDDS-CDG

Clinical trials for DHDDS-CDG explained in plain language.

Never miss a new study

Get alerted when new DHDDS-CDG trials appear

Sign up with your email to follow new studies for DHDDS-CDG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a common supplement help rare disease? small study begins

Knowledge-focused Not yet recruiting

This study aims to see if the dietary supplement NMN is safe for people with a rare genetic condition called DHDDS-CDG. Eight participants aged 4 and older will take NMN for 6 months, with a follow-up at 12 months. The main goal is to check for side effects and gather information…

Matched conditions: DHDDS-CDG

Phase: PHASE1 • Sponsor: Eva Morava-Kozicz • Aim: Knowledge-focused

Last updated May 09, 2026 05:18 UTC

DHDDS-CDG

Get alerted when new DHDDS-CDG trials appear

Could a common supplement help rare disease? small study begins